Viridian Therapeutics (NasdaqCM:VRDN) Update / briefing March 30, 2026 08:00 AM ET Company ParticipantsAlex Thompson - Research Managing Director of Biotech Equity ResearchFaisal Khurshid - Managing Director of Equity ResearchGavin Clark-Gartner - Managing Director of Biotechnology Equity ResearchGreg Rossino - Senior Director of Investor RelationsGregory Renza - Managing DirectorJason Butler - Managing DirectorLaura Chico - Managing DirectorLisa Walter - VPRadhika Tripuraneni - Chief Medical OfficerShan Wu ...